The majority of funds, 41% (€144,000), are allocated to our founding team, ensuring dedicated focus on product, neuroscience design, and early traction. AI infrastructure and inference costs account for 22% (€78,000), supporting a controlled beta with up to 300 active users. Essential product development and specialized contractors make up 12% (€41,000), while 10% (€34,000) is reserved for US incorporation and relocation. A 9% contingency buffer (€31,000) is for unforeseen needs, with the remaining 6% (€22,000) dedicated to operations and go-to-market activities.